NCT03239444 is a Phase 1 clinical trial of Intracardiac echocardiography imaging in Atrial Fibrillation, sponsored by Conavi.

Who is sponsoring NCT03239444?

NCT03239444 is sponsored by Conavi.

What drugs are being tested in NCT03239444?

Interventions in NCT03239444: Intracardiac echocardiography imaging.

What condition does NCT03239444 study?

NCT03239444 studies Atrial Fibrillation.

Is NCT03239444 still recruiting?

NCT03239444 is currently completed. Last updated 23 July 2019.

Last reviewed 2019-07-23 · How we verify

NCT03239444

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Foresight Intracardiac Echocardiography System (ICE)

Completed Phase 1 Last updated 23 July 2019

What this trial tests

Phase 1 trial testing Intracardiac echocardiography imaging in Atrial Fibrillation in 13 participants. Completed in 24 December 2018.

Timeline

24 April 2017

Primary endpoint
24 December 2018

24 December 2018

Quick facts

Lead sponsor	Conavi
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	device feasibility
Enrollment	13
Start date	24 April 2017
Primary completion	24 December 2018
Estimated completion	24 December 2018
Sites	1 location across Canada

Drugs / interventions tested

Intracardiac echocardiography imaging

Conditions studied

Atrial Fibrillation — all drugs for Atrial Fibrillation →

Sponsor

Conavi

Who can join

18 and older, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate the efficacy of the Foresight Intracardiac Echocardiography system ,with improved image quality, in guiding trans-septal punctures during atrial fibrillation ablation procedures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting

Other Conavi trials

Trials by the same sponsor.

NCT03484975 — Novasight Hybrid Intravascular Ultrasound and Optical Coherence Tomography System (IVUS OCT) · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03239444 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Conavi
Last refreshed: 23 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03239444.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing